Evidence map›Paper›PMID 15709002›Full record

ArticleJournal of virology2005

Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences.

Philomena Ostapchuk, Jihong Yang, Ece Auffarth, Patrick Hearing

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Mysteries of adenovirus packaging.Journal of virology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Components of Adenovirus Genome Packaging.Frontiers in microbiology · 2016
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Philomena OstapchukDepartment of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
Jihong Yang
Ece Auffarth
Patrick Hearing
Stony Brook University · US

Funding

ADENOVIRUS AS A VECTOR FOR GENE THERAPYR01AI041636 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI HEARING, PATRICK · 1997 to 2011
$3.6M
NIAID NIH HHS AI41636NIAID NIH HHS R01 AI041636
6 · The paper itself

Abstract

Adenovirus type 5 (Ad5) DNA packaging is initiated in a polar fashion from the left end of the genome. The packaging process is dependent on the cis-acting packaging domain located between nucleotides 230 and 380. Seven AT-rich repeats that direct packaging have been identified within this domain. A1, A2, A5, and A6 are the most important repeats functionally and share a bipartite sequence motif. Several lines of evidence suggest that there is a limiting trans-acting factor(s) that plays a role in packaging. Both cellular and viral proteins that interact with adenovirus packaging elements in vitro have been identified. In this study, we characterized a group of recombinant viruses that carry site-specific point mutations within a minimal packaging domain. The mutants were analyzed for growth properties in vivo and for the ability to bind cellular and viral proteins in vitro. Our results are consistent with a requirement of the viral IVa2 protein for DNA packaging via a direct interaction with packaging sequences. Our results also indicate that higher-order IVa2-containing complexes that form on adjacent packaging repeats in vitro are the complexes required for the packaging activity of these sites in vivo. Chromatin immunoprecipitation was used to study proteins that bind directly to the packaging sequences. These results demonstrate site-specific interaction of the viral IVa2 and L1 52/55K proteins with the Ad5 packaging domain in vivo. These results confirm and extend those previously reported and provide a framework on which to model the adenovirus assembly process.

Indexed as

Adenoviruses, HumanBase SequenceCell LineDNA ReplicationDNA, ViralGenes, ViralHomeodomain ProteinsHumansMultiprotein ComplexesNuclear ProteinsPoint MutationProtein BindingRepressor ProteinsSequence Homology, Nucleic AcidTranscription FactorsViral ProteinsCUX1 protein, humanDNA, ViralHomeodomain Proteinsiva2 protein, adenovirusMultiprotein ComplexesNuclear ProteinsRepressor ProteinsTranscription FactorsViral ProteinsViral Structural Proteins

Identifiers

PMID15709002
PMCPMC548476
OpenAlexW2143408261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.